By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.
Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.
Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.
A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.
February 26, 2026
During the EUCROF 2026 gala dinner in Amsterdam, in front of 300+ participants from the European clinical research ecosystem, the xShare project Open Call Awards for Clinical Research were officially presented. We are extremely proud that Telemedicine Technologies contributed to three complementary xShare Open Call projects (out of 10), all recognised for their quality, innovation […]
January 29, 2026
Medtech Dive Amid a deregulatory push by the Trump administration, the Food and Drug Administration is scrutinizing its digital health policies. The agency suddenly issued a pair of guidances earlier this month, intended to clarify its approach to wellness devices and medical software. The updates reflect changes to the agency’s thinking about what counts as a wellness […]
January 29, 2026
Med City News The Covid-19 pandemic impacted virtually every industry, with healthcare arguably undergoing the most drastic transformation. Pre-pandemic, most of us never could’ve imagined routine doctor visits happening over telehealth, or a brand-new vaccine being developed, tested, and authorized for emergency use in under a year. The urgency of the pandemic forced medical scientists […]